
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Rohan Garje is a medical oncologist and the chief of genitourinary medical oncology at Miami Cancer Institute in Florida.